110.75
-1.3(-1.16%)
Currency In EUR
Address
Frankfurter Strasse 250
Darmstadt, 64293
Germany
Phone
49 6151 72 0
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
59020
First IPO Date
June 26, 1998
| Name | Title | Pay | Year Born |
| Dr. Kai Beckmann | Chief Executive Officer of Electronics & Member of the Executive Board | 4.99M | 1965 |
| Dr. Matthias J. Heinzel | Chief Executive Officer of Life Science Sector & Member of Executive Board | 5.37M | 1967 |
| Mr. Peter Guenter | Chief Executive Officer of Healthcare Business & Member of Executive Board | 5.76M | 1962 |
| Ms. Belen Garijo Lopez M.D. | Chair of Executive Board & Chief Executive Officer | 6.79M | 1960 |
| Ms. Helene von Roeder | Chief Financial Officer & Member of Executive Board | 3.52M | 1970 |
| Dr. Michael Heckmeier | Head of the Display Materials Business Unit for Performance Materials | 0 | 1967 |
| Mr. Frank Gotthardt | Head of Corporate & Government Relations - Europe | 0 | N/A |
| Mr. Marc Horn | Head of Life Science Controlling | 0 | 1975 |
| Mr. Dietmar Eidens | Head of the Global HR Business Partner Organization | 0 | 1958 |
| Ms. Barbara Weiland | Chief Compliance Officer | 0 | 1974 |
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.